iMeds.se

Sertralin Tiefenbacher

Document: Sertralin Tiefenbacher film-coated tablet ENG PL change

Package leaflet: Information for the user


SertralineTiefenbacher 50 mg film-coated tablets

SertralineTiefenbacher 100 mg film-coated tablets

Sertraline


Read all of this leaflet carefully before you start taking this medicinebecause it contains important information for you.


What is inthis leaflet

What Sertraline Tiefenbacher is and what it is used for

What you need to know before you take Sertraline Tiefenbacher

How to take Sertraline Tiefenbacher

Possible side effects

How to store Sertraline Tiefenbacher

Contents of the pack and other information


What Sertraline Tiefenbacher is and what it is used for


SertralineTiefenbacher contains the active ingredient sertraline. Sertraline is one of a group of medicines called Selective Serotonin Re-uptake Inhibitors (SSRIs); these medicines are used to treat depression and or anxiety disorders.


SertralineTiefenbacher can be used to treat


Depression is a clinical illness with symptoms like feeling sad, unable to sleep properly or to enjoy life as you used to.


OCD and Panic disorders are illnesses linked to anxiety with symptoms like being constantly troubled by persistent ideas (obsessions) that make you carry out repetitive rituals (compulsions).


PTSD is a condition that can occur after a very emotionally traumatic experience, and has some symptoms that are similar to depression and anxiety. Social anxiety disorder (social phobia) is an illness linked to anxiety. It is characterised by feelings of intense anxiety or distress in social situations (for example: talking to strangers, speaking in front of groups of people, eating or drinkingin front of others or worrying that you might behave in an embarrassing manner).


Your doctor has decided that this medicine is suitable for treating your illness.


You should ask your doctor if you are unsure why you have been given SertralineTiefenbacher.


What you need to know before you take Sertraline Tiefenbacher


Do not take SertralineTiefenbacher:


Warnings and precautions

Medicines are not always suitable for everyone. Talk toyour doctor before taking SertralineTiefenbacher, if you sufferfrom or have suffered in the past from any of the following conditions:



Restlessness/Akathisia

The use of sertraline has been linked to a distressing restlessness and need to move, often being unable to sit or stand still(akathisia). This is most likely to occur during the first few weeks of treatment. Increasing the dose may be harmful so if youdevelop such symptomsyou should talk to your doctor.


Withdrawal reactions

Side effects relating to stoppingtreatment (withdrawal reactions)are common, particularly if the treatment is stopped suddenly (seesection 3 If you stop taking Sertraline Tiefenbacher andsection 4 Possible side effects). The risk of withdrawal symptoms depends on the length of treatment, dosage, and the rate at which the dose is reduced. Generally, such symptoms are mild to moderate. However, they can be serious in some patients. They normally occur within the first few days after stopping treatment. In general, such symptoms disappear on their own and wear off within 2 weeks. In some patients they may last longer (2-3 months or more). When stopping treatment with sertralineit is recommended to reduce the dose gradually over a period of several weeks or months, and you should always discussthe best way of stopping treatment with your doctor.


Thoughts of suicide and worsening of your depression or anxiety disorder

If you are depressed and/or have anxiety disorders you can sometimes have thoughts of harming or killing yourself. These may be increased when first starting antidepressants, since these medicines all take time to work, usually about two weeks but sometimes longer.


You may be more likely to think like this:

If you have thoughts of harming or killing yourself at any time, contact your doctor or go to a hospital straight away.

You may find it helpful to tell a relative or close friend that you are depressed or have an anxiety disorder, and ask them to read this leaflet. You might ask them to tell you if they think your depression or anxiety is getting worse, or if they are worried about changes in your behaviour.


Childrenand adolescents

Sertraline should not usually be used in children and adolescents less than 18 years old, except for patients with Obsessive Compulsive Disorder(OCD).Patients under 18 have an increased risk of undesirable effects, such as suicide attempt, thoughts of harming or killing themselves (suicidal thoughts)and hostility (mainly aggressiveness, oppositional behaviour and anger) when they are treated with this class of medicines. Nevertheless, it is possible that your doctor decides to prescribe SertralineTiefenbacher to a patient under 18 if it is in the patient's interest. If your doctor has prescribed SertralineTiefenbacher to you and you areless than 18 years old and you want to discuss this, please contact him/her. Furthermore, if any of the symptoms listed above appear or worsen while you aretaking SertralineTiefenbacher, you should inform your doctor. Also, the long-term safety of SertralineTiefenbacher in regard to growth, maturation and learning (cognitive)and behavioural development in this age group has not yet been demonstrated.


Othermedicinesand Sertraline Tiefenbacher

Tellyour doctor if you are taking,have recently taken or might take any other medicines.


Some medicines can affect the way SertralineTiefenbacher works, or SertralineTiefenbacher itself can reduce the effectiveness of other medicines taken at the same time.


Taking SertralineTiefenbacher together with the following medicines may cause serious side effects


Talk to your doctor if you are taking the following medicine


SertralineTiefenbacher with food,drinkand alcohol


SertralineTiefenbacher tablets can be taken with or without food.


Alcohol should be avoided whilst taking SertralineTiefenbacher.


Sertraline should not be taken in combination with grapefruit juice, as this may increase the level of sertraline in your body.


Pregnancy, breast-feeding and fertility

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, askyour doctor or pharmacist for advice before taking thismedicine.


The safety of sertraline has not fully been established in pregnant women. Sertraline will only be given to you when pregnant if your doctor considers that the benefit for you is greater than any possible risk to the developing baby. If you are a women capable of having children you should use a reliable method of contraception (such as the contraceptive pill), when taking sertraline.


Make sure your midwife and/or doctor know you are on SertralineTiefenbacher. When taken during pregnancy, particularly in the last 3 months of pregnancy, medicines like SertralineTiefenbacher may increase the risk of a serious condition in babies, called persistent pulmonary hypertension of the newborn (PPHN), making the baby breathe faster and appear bluish. These symptoms usually begin during the first 24 hours after the baby is born. If this happens to your baby you should contact your midwife and/or doctor immediately.


Your newborn baby might also have other conditions, which usually begin during the first 24 hours after birth. Symptoms include:


If your baby has any of these symptoms when it is born, or you are concerned about your baby’s health, contact your doctor or midwife who will be ableto advise you.


There is evidence that sertraline passes intohuman breast milk. Sertraline should only be used in women during lactation, if yourdoctor considers that the benefit exceeds any possible risk to the baby.


Some medicines like sertraline may reduce the quality of sperm in animal studies. Theoretically, this could affect fertility, but impact on human fertility has not been observed as yet.


Driving and using machines

Psychotropic drugs such as sertraline may influence your ability to drive or use machines. You should therefore not drive or operate machinery, until you know how this medication affects your ability to perform these activities.


SertralineTiefenbachercontainslactose

If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.


How to take Sertraline Tiefenbacher


Always take this medicineexactly as your doctor has told you.Check with your doctor if you are not sure.


SertralineTiefenbacher tablets may be taken with or without food.

Take your medication once daily either in the morning or evening.


The recommendeddose is

Adults:

Depression and ObsessiveCompulsive Disorder

For depression and OCD, the usual effective dose is 50 mg/day. The daily dose may be increased in 50 mg increments and at intervals of at least one week over a period of weeks. The maximum recommended dose is 200 mg/day.


Panic disorder, Social anxiety disorder and Post Traumatic Stress Disorder

For panic disorder, social anxiety disorder and post traumatic stress disorder, treatment should be started at 25 mg/day, and increased to 50 mg/day after one week. The daily dose then may be increased in 50 mg increments over a period of weeks. The maximum recommended dose is 200 mg/day.


Children and adolescents

SertralineTiefenbacher must only be used to treat children and adolescents suffering from OCD aged 6-17 years old.

Obsessive Compulsive Disorder

Children aged 6 to 12: the recommended starting dose is 25 mg daily.

After one week, your doctor may increase this to 50 mg daily. The maximum dose is 200 mg daily.

Adolescents aged 13 to 17: the recommended starting dose is 50 mg daily.

The maximum dose is 200 mg daily.


If you have liver or kidney problems, please tell your doctor and follow the doctor’s instructions.


Your doctor will advise you on how long to take this medication for. This will depend on the nature of your illness and how well you are responding to the treatment. It may take several weeks before your symptoms begin to improve. Treatment of depression should usually continue for 6 months after improvement.


The tablet can be divided into equal doses.


If you take more SertralineTiefenbacher than you should

If you accidentally take too much SertralineTiefenbacher contact your doctor at once or go to the nearest hospital casualty department. Always take the labelled medicine package with you, whether there is any medication left or not.


Symptoms of overdose may include drowsiness, nausea and vomiting, rapid heartrate, shaking, agitation, dizziness and in rare cases unconsciousness.


If you forget to take SertralineTiefenbacher

If you forget to take a dose, do not take the missed dose. Just take the next dose at the right time.

Do not take a double dose to make up for a forgotten dose.


If you stop taking SertralineTiefenbacher

Do not stop taking SertralineTiefenbacher unless your doctor tells you to. Your doctor will want to gradually reduce your dose of SertralineTiefenbacher over several weeks, before you finally stop taking this medicine. If you suddenly stop taking this medicine you may experience side effects such as dizziness, numbness, sleep disturbances, agitation or anxiety, headaches, feeling sick, being sick and shaking. If you experience any of these side effects, or any other side effects whilst stopping taking SertralineTiefenbacher, please speak to your doctor.


If you have any further questions on the use of this medicine, ask your doctor or pharmacist.


Possible side effects


Like all medicines, this medicinecan cause side effects, although not everybody gets them.


If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.


Nausea is the most common side effect. The side effects depend on the dose and often disappear or lessenwith continued treatment.


Tell your doctor immediately

If you experience any of the following symptoms after taking this medicine, these symptoms can be serious.


The following side effects were seen in clinical trials in adults.


Very common side effects (occurs in more than 1 out of 10 patients):

Insomnia, dizziness, sleepiness, headache, diarrhoea, feeling sick, dry mouth, ejaculation failure, fatigue.


Common side effects (occurs in between 1 and 10 out of 100 patients):


Uncommon side effects (occurs in between 1 and 10 out of 1.000 patients):


Rare side effects (occurs in between 1 and 10 out of 10.000 patients):


After marketing sertraline, the following side effects have been reported


Side effects in children and adolescents

In clinical trials with children and adolescents, the side effects were generally similar to adults (see above). The most common side effects in children and adolescents were headache, insomnia, diarrhoea and feeling sick.


Symptoms that can occur when treatment is discontinued

If you suddenly stop taking this medicine you may experience side effects such as dizziness, numbness, sleep disturbances, agitation or anxiety, headaches, feeling sick, being sick and shaking (see section 3. “If you stop taking Sertraline Tiefenbacher.


An increased risk of bone fractures has been observed in patients taking this type of medicines.


Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via <to be completed nationally>. By reporting side affects you can help provide more information on the safety of this medicine.


How to store Sertraline Tiefenbacher


Keep out of the sight and reach of children.


Do not use this medicineafter the expiry date which is stated on the packafter EXP. The expiry date refers to the last day of that month.


This medicinal product does not require any special storage conditions.


Donot throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw awaymedicines you no longer use. These measures will help protect the environment.


Contents of the pack and other information


What SertralineTiefenbacher contains


The active substance is: sertraline.

SertralineTiefenbacher 50 mg film-coated tablets:

Each film-coated tablet contains 50 mg sertraline (as hydrochloride).


SertralineTiefenbacher 100 mg film-coated tablets:

Each film-coated tablet contains 100 mg sertraline (as hydrochloride).


The other ingredients are:

Core: lactose monohydrate, cellulose microcrystalline, povidone K30, croscarmellose sodium, magnesium stearate.

Coating: hypromellose 6 (for SertralineTiefenbacher 50 mg), hypromellose 6 & hypromellose 15 (for SertralineTiefenbacher 100 mg), talc, propylene glycol and titanium dioxide (E 171).


What SertralineTiefenbacher looks like and contents of the pack


SertralineTiefenbacher 50 mg film-coated tablets:

White, oval film-coated tablets. Both sides are curved outwards. They are scored on one side and marked “L” on the other side. The tablet can be devided into equal doses.


SertralineTiefenbacher 50 mg is available in packs of

Blister of PVC/PVDC/aluminium in a carton: 7, 10, 14, 15, 20, 28, 30, 50, 60, 98 and 100 tablets.

Single dose blister of PVC/PVDC/aluminium in a carton: 28x1, 30x1, 50x1, 98x1 and 100x1 tablets.

Round HDPE bottles with LDPE snap-on closures: 100, 250 and 500 tablets.


Not all pack sizes may be marketed.


SertralineTiefenbacher 100 mg film-coated tablets:

White, round film-coated tablets. Both sides are curved outwards. They are scored on one side and marked “C” on the other side. The tablet can be devided into equal doses.


SertralineTiefenbacher 100 mg is available in packs of

Blister of PVC/PVDC/aluminium in a carton: 7, 10, 14, 15, 20, 28, 30, 50, 60, 98 and 100 tablets.

Single dose blister of PVC/PVDC/aluminium in a carton: 28x1, 30x1, 50x1, 98x1 and 100x1 tablets.

Round HDPE bottles with LDPE snap-on closures: 100, 250 and 500 tablets.


Not all pack sizes may be marketed.


Marketing Authorisation Holder and Manufacturer


<to be completed nationally>


Manufacturer


<to be completed nationally>


This medicinal product is authorised in the Member States of the EEA under the following names:


[to be completed nationally]


This leaflet was last revised in June 2013